Consensus statements provide useful guidance on current clinical practice patterns and disease pathophysiology in an ever-evolving landscape of patient care.
An expert consensus was recently published by Kolomeyer and colleagues to gain insight into current understanding of the role of inflammation in diabetic macular edema pathophysiology and the efficacy and safety of the 0.19 mg fluocinolone acetonide (FAc) implant, Iluvien (Alimera Sciences).
Expert surveys of this type provide an important snapshot of our understanding of DME and clarify where the FAc implant fits in with the current